?
Titterton Lewis H Jr
Director
Anixa Biosciences, Inc.
US, San Jose [HQ]
CIK
1499254
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
894,070
Price per Share :
$2.28
Equivalence :
$2,038,479.60
Transaction History
-
M894,070 Shares After TransactionValue : $2,306,700.60$309,600.00Transaction Date : 07/27/23
-
Footnotes
-
-
Footnotes:#1 The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
-
F807,028 Shares After TransactionValue : $2,864,949.40$308,999.10Transaction Date : 07/27/23
-
Footnotes
-
-
Footnotes:#1 The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
-
M774,070 Shares After TransactionValue : $1,997,100.60$103,200.00Transaction Date : 09/29/22
-
Footnotes
-
-
Footnotes:No footnote found.
-
P849,105 Shares After TransactionValue : $2,207,673.00$858.00Transaction Date : 06/10/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
P856,207 Shares After TransactionValue : $2,277,510.62$18,891.32Transaction Date : 06/11/24
-
Footnotes
-
-
Footnotes:No footnote found.